Syntara to Begin Phase Two Study for SNT-5505 Combination Therapy Later in 2024 After Government Grant
Syntara to Begin Phase Two Study for SNT-5505 Combination Therapy Later in 2024 After Government Grant
在政府拨款后，Syntara 将于 2024 年晚些时候开始 SNT-5505 联合疗法的第二阶段研究
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间